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Abstract
Introduction: There is considerable individual and racial variation in the degree and pattern of body hair among PCOS patients. The 
purposes of this study were to define: 1) a suitable standard of hirsutism for Chinese women with PCOS and the general Chinese popula-
tion; 2) the characteristics of hair distribution and degree in Chinese women with PCOS and the general population; and 3) the correlation 
of PCOS and FG score in Chinese women.
Material and methods: This retrospective study in Chinese women with PCOS in the reproductive centre of Sun Yat-Sen Memorial Hos-
pital, Sun Yat-Sen University, comprised 850 patients with PCOS and 2,988 members of the general population. It was conducted cross-
sectionally by interview, physical examination, ultrasound scan, and modified Ferriman-Gallwey score. Eight hundred and fifty Chinese 
women with PCOS (aged 20–41) underwent an interview, blood drawing, physical and ultrasound examination. Body hair at nine sites 
(lip, chin, arm, thigh, chest, upper belly, lower belly, upper back and lower back) were evaluated using the scoring system described by 
Ferriman and Gallwey; 2,988 healthy women (aged 20–45) underwent an interview, physical examination, ultrasound scan and FG score 
evaluation by trained gynaecologists. Terminal body hair growth was assessed using the mFG scoring system in Chinese women with 
PCOS and the control group; nine body areas were scored from 0–4 for terminal hair growth distribution.
Results: Our findings showed that of the 850 patients, 367 had a FG score equal to or greater than 5 points [43.2% (367/850)], 282 patients had 
a FG score equal to or greater than 6 points [33.18% (282/850)], and 21% had a score of at least 8 points. Nobody’s FG score was equal to or greater 
than 24 points. Hirsutism was significantly higher in PCOS patients (score≥ 5 = 43.2%) than in the general population (score ≥ 5 = 10%). The lip 
is the most common place (score 0–3) where terminal hair grows in 850 PCOS patients and the general population. Next came the upper back 
and chest, and the number of 4 points was only recorded for the region of the lip (16), thigh (3), lower belly (3), arm (1), chest (1), and lower back 
(1). None of the PCOS patients displayed a score of more than 4 points for the chin, upper belly and upper back.
Conclusions: Our data indicates that: 1) an mFG score of 5 or above is out of the norm for the general unselected population and forms 
almost half of the possibility of diagnosing PCOS in Chinese women; 2) lips and upper back are the most common places that hair grows 
(score 1–2), but in terms of the serious situation (score 3–4), lips and thighs are the most common places that hair grows; 3) there is 
a good predictive value to diagnose PCOS by FG score for Chinese people; and 4) hirsutism is more common in PCOS than in the general 
population in China. (Endokrynol Pol 2014; 65 (5): 365–370)
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Streszczenie
Wstęp: Wśród pacjentek z zespołem policystycznych jajników (PCOS) obserwuje się znaczną indywidualną i rasową zmienność nasile-
nia i rozkładu owłosienia ciała. Cele tego badania obejmowały określenie: 1) odpowiedniego standardu hirsutyzmu u Chinek z PCOS 
i w populacji ogólnej; 2) charakterystyki rozkładu i nasilenia owłosienia u Chinek z PCOS i w populacji ogólnej; oraz 3) korelacji między 
PCOS a wynikiem w skali Ferrimana-Gallweya (FG) u Chinek. 
Materiał i metody: Retrospektywnym badaniem w populacji Chinek z PCOS w ośrodku leczenia zaburzeń rozrodu w Sun Yat-Sen 
Memorial Hospital, Sun Yat-Sen University, objęto 850 pacjentek z PCOS i 2988 kobiet z populacji ogólnej, u których dokonano oceny 
na podstawie wywiadów, badania przedmiotowego, oceny ultrasonograficznej oraz zmodyfikowanej skali FG. U 850 Chinek z PCOS 
(wiek 20-41 lat) zebrano wywiady, pobrano krew, przeprowadzono badanie fizykalne i ultrasonograficzne oraz oceniono owłosienie ciała 
w 9 miejscach (warga, podbródek, ramię, udo, klatka piersiowa, nadbrzusze, podbrzusze oraz górna i dolna część pleców), posługując się 
systemem punktowym opisanym przez Ferrimana i Gallweya, a u 2988 zdrowych kobiet (wiek 20–45 lat) zebrano wywiady, przeprowadzo-
no badanie fizykalne i ultrasonograficzne oraz dokonano oceny w skali FG. Ocena była dokonywana przez wyszkolonych ginekologów. 
Wzrost i rozkład włosów końcowych na ciele oceniono za pomocą zmodyfikowanej skali FG u Chinek z PCOS oraz w grupie kontrolnej, 
określając wartości punktowe w skali od 0 do 4 dla dziewięciu okolic ciała.
Wyniki: Wśród 850 pacjentek z PCOS wynik ≥ 5 punktów w skali FG uzyskano u 367 pacjentek [43,2% (367/850)], wynik ≥ 6 punktów 
u 282 pacjentek [33,18% (282/850)], a co najmniej 8 punktów u 21% pacjentek. U żadnej pacjentki nie uzyskano wyniku ≥ 24 punkty. Nasilenie 
hirsutyzmu było istotnie większe wśród pacjentek z PCOS (wynik ≥ 5 punktów u 43,2%) niż w populacji ogólnej (wynik ≥ 5 punktów u 10%). 
Warga była najczęstszym miejscem wzrostu włosów końcowych (wynik 0–3 pkt.) u 850 pacjentek z PCOS oraz w populacji ogólnej, 
a następne miejsca pod względem częstości wzrostu włosów zajęły górna część pleców i klatka piersiowa. Wzrost włosów oceniony na 
4 punkty odnotowano tylko w okolicach wargi (n = 16), uda (n = 3), podbrzusza (n = 3), ramion (n = 1), klatki piersiowej (n = 1) oraz 
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dolnej części pleców (n = 1). U żadnej z pacjentek z PCOS nie odnotowano wzrostu włosów ocenionego na 4 punkty w okolicach pod-
bródka, nadbrzusza i górnej części pleców.
Wnioski: Nasze dane wskazują, że: 1) wynik w zmodyfikowanej skali FG wynoszący ≥ 5 punktów jest poza normą w nieselekcjonowanej 
populacji ogólnej i stwierdza się go u prawie połowy Chinek z rozpoznaniem PCOS; 2) warga i górna część pleców były najczęstszymi 
miejscami wzrostu włosów (wynik 1–2 pkt.), ale najbardziej nasilony wzrost (wynik 3–4 pkt.), stwierdzono w obrębie wargi i ud; 3) Roz-
poznawanie PCOS na podstawie wyniku w skali FG u Chinek charakteryzuje się dobrą wartością predykcyjną; 4) hirsutyzm u Chinek 
jest częstszy wśród pacjentek z PCOS niż w populacji ogólnej. (Endokrynol Pol 2014; 65 (5): 366–370)
Słowa kluczowe: hirsutyzm; wzrost włosów; zmodyfikowana skala Ferrimana-Gallweya; zespół policystycznych jajników; Chinki
of body terminal hair growth. Therefore, there is still 
considerable disagreement as to the cutoff score for 
hirsutism in Chinese women with PCOS [13, 15, 17–19]. 
To gain insight into this, we conducted this retrospective 
study to define 1) a suitable standard of hirsutism for 
Chinese women with PCOS and the general popula-
tion; 2) the characteristics and degree of hair distribu-
tion in Chinese women with PCOS and the general 
population; and 3) the correlation of PCOS and FG 
score in Chinese women. We attempted to compare the 
scoring of hirsutism in Chinese women with PCOS to 
that of the general population.
Material and methods
Study population
PCOS patients (n = 1,668) seeking medical advice for 
menstrual cycle abnormalities, hirsutism, acne, obe-
sity or infertility were consecutively recruited from 
the outpatient clinic of the reproductive centre, the 
Department of Obstetrics and Gynaecology at the Sun 
Yat-Sen Hospital Zhongshan University between May 
2007 and April 2010. Based on criteria derived from 
the 2003 Rotterdam criteria, a diagnosis of PCOS was 
established when either oligomenorrhea (cycles last-
ing longer than 35 days) or amenorrhea (less than two 
menstrual cycles in the past six months) and clinical 
signs of hyperandrogenism (hirsutism and/or obvious 
acne and/or alopecia) were found; hyperandrogenemia 
was not used for the diagnosis of PCOS. Other pituitary, 
adrenal or ovarian diseases were excluded in all women 
by laboratory analysis of LH, FSH, oestradiol, prolactin, 
cortisol, adrenocorticotropic hormone (ACTH), thyroid-
stimulating hormone (TSH) and androstendione. In 
addition, in all women with 17-hydroxyprogesterone 
(17-OHP) levels < 10 ng/mL, ACTH testing with meas-
urement of 17-OHP was performed. When either the 
basal or stimulated value was < 10 ng/mL, genetic 
analysis (21-hydroxylase deficiency) was performed. 
Polycystic ovaries were defined according to the 
ESHRE/ASRM (European Society for Human Repro-
duction/American Society of Reproductive Medicine) 
criteria when either a volume of at least 10mL or more 
than 12 follicles (diameter 2–9 mm) were found in at 
least one ovary. PCOS subjects had taken no medica-
Introduction
Doctors frequently encounter hirsute patients. Quan-
tification of hair growth may be useful for diagnosis 
and follow-up. It is very important to establish the 
reference range for distribution of hair in females, and 
to determine the regions yielding the best discrimina-
tion between normal and hirsute women. 
Hirsutism is one of the important features of poly-
cystic ovary syndrome (PCOS) [1–3], and PCOS is the 
most prevalent endocrine disorder of reproductive age 
women, affecting between 7% and 12% of unselected 
white or black women [4–8]. Several years ago, there was a 
domestic small-scale epidemiological survey in some areas 
of China, and the results indicated that the prevalence of 
PCOS in reproductive age women was 6.46–7.2% on the 
diagnosis of PCOS recommended in the 2003 Rotterdam 
criteria. In recent years, a nationwide, large sample, multi-
centre study in China has shown that the prevalence of 
PCOS in reproductive age women was 11.8% [9]. Given 
China’s large population of 1.3 billion, and that females 
account for half of the total, according to the prevalence 
rate of the study the consequences could be disastrous. 
Some studies covering different races have reported that 
PCOS is associated with a greater degree of metabolic 
complications [10–11]. Because of this, we need to study and 
investigate the disease urgently. 
The most common visual method of scoring the extent of 
body and facial terminal hair growth in use today is based 
on a modification of the method originally described by 
Ferriman and Gallwey in 1961. This originally regarded 
a total score of greater than 8 points as the cutoff value 
[12] but Ferriman himself later chose a cutoff score of 
5 or more when defining hirsutism [13]. Knochenhauer 
revised the total score greater than 6 points as the diag-
nostic criteria and this is now the commonly-used scale 
[14]. Cewadhanaraks purposed a cutoff score to diagnose 
hirsutism of ≥ 3 among Thai women [15]. Rotterdam 
diagnostic hirsutism criteria indicate that there may be 
differences between races because there is still a lack of 
epidemiological information. Because of the differences 
between regions and races, the definition of hirsutism is 
still unclear, particularly in Chinese women [16]. 
Few studies have looked at China mainland women, 
either the distribution characteristics or the degree 
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tion known to affect either carbohydrate metabolism or 
endocrine parameters for at least three months before 
entering the study. Women taking contraceptive pills 
were excluded from the study. NIH criteria were used 
to exclude PCOS in controls before entering the study. 
The control group (2,988) was a cross-sectional epide-
miological study using a stratified, multistage systematic 
cluster random sampling in 16 communities (a hospital, 
company, factory, or village) of two urban and two rural 
regions in the Guangdong province of China. Interven-
tions included an interview, physical examination and 
ultrasound scan by pooled trained gynaecologists. Partici-
pants included a nationally representative sample of 2,988 
Southern Chinese women aged 20–45 years. 
Data collection
There were 1,668 PCOS patients originally, but some 
of them were excluded because of incomplete informa-
tion; eventually, there were 850 patients left. All the 
doctors had been trained by a professor of gynaecol-
ogy in conducting interviews, physical examinations, 
and ultrasound scans in a uniform manner. Physical 
examination, morning fasting blood drawing, and 
ultrasound scan were carried out. A complete physi-
cal examination, including the measurement of height 
(cm), weight (kg), and waist to hip circumference 
(cm); evaluation of body hair grading according to 
the modified Ferriman and Gallwey system, grading 
nine body areas including the upper lip, chin, chest, 
upper and lower abdomen, thighs, upper and lower 
back, arm, from 0 (no hair) to 4 (frankly virile); the 
presence of acne, oily skin, androgenic alopecia, and 
acanthosis nigricans; and the examination of thyroid 
and breast. All the patients underwent a transvaginal 
or transrectal ovarian ultrasound, Oligomenorrhea/
amenorrhea was defined as a cycle length > 35 days 
and no cycles for six or more consecutive months, re-
spectively. Polycystic ovaries were defined as having 
≥ 12 follicles or an ovarian volume ≥ 10 cm3 in at least 
one ovary. Other related disorders, such as hyperpro-
lactinemia, nonclassic adrenal hyperplasia, or thyroid 
disease, were excluded. 
The general population (2,988) were Southern 
Chinese women aged 20–45 years who conducted an 
epidemiological study using a stratified, multistage 
systematic cluster random sampling in 16 communities 
(a hospital, company, factory, or village) of two urban and 
two rural regions in the Guangdong province of China.
Statistical analysis
Statistical analysis was done with SPSS 11.0 (SPSS, Chi-
cago, IL, USA). In the study group, we used numbers 
and percentiles to describe all the results. In the control 
group, we use K-means to statistise.
Results and discussion
The results are shown in Tables I–III and in Figure 1.
Table I. 850 PCOS patients’ FG score (0–4) in nine body areas
Tabela I. Liczba pacjentek z PCOS (n = 850) z poszczególnymi wynikami w zmodyfikowanej skali Ferrimana-Gallweya 
(0–4 pkt.) w dziewięciu okolicach ciała
Region/score 0 (%) 1 (%) 2 (%) 3 (%) 4 (%)
Lip 113 (13.29) 364 (42.82) 251 (29.53) 106 (12.47) 16 (1.88)
Chin 750 (88.24) 82 (9.65) 15 (1.76) 3 (0.35) 0 (0)
Arm 677 (79.65) 118 (13.88) 43 (5.06) 11 (1.29) 1 (0.12)
Thigh 590 (69.41) 150 (17.65) 82 (9.65) 25 (2.94) 3 (0.35)
Chest 469 (55.18) 331 (38.94) 45 (5.29) 4 (0.47) 1 (0.12)
Upper belly 659 (77.53) 160 (18.82) 29 (3.41) 2 (0.24) 0 (0)
Lower belly 511 (60.12) 258 (30.35) 66 (7.76) 12 (1.41) 3 (0.35)
Upper back 367 (43.18) 314 (36.94) 147 (17.29) 22 (2.59) 0 (0)
Lower back 587 (69.06) 184 (21.65) 64 (7.53) 14 (1.65) 1 (0.12)
1. The order of the number scoring 0 points from most to least: chin (88.24%) > arm (79.65%) > upper belly (77.53%) > thigh (69.41%) > lower back > (69.06%) > 
lower belly (60.12%) > chest (55.18%) > upper back (43.18%) > lip (13.29%).
2. The order of the number scoring 1 point from most to least: Lip (42.82%) > chest (38.94%) > upper back (36.94%) > lower belly (30.35%) > lower back > 
(21.65%) > upper belly (18.82%) > thigh (17.65%) > arm (13.88%) > chin (9.65%).
3. The order of the number scoring 2 points from most to least: Lip (29.53%) > upper back (17.29%) > thigh (9.65%) > lower belly (7.76%) > lower back (7.53%) > 
chest (5.29%) > arm (5.06%) > upper belly (3.41%) > chin (1.76%).
4. The order of the number scoring 3 points from most to least: Lip (12.47%) > thigh (2.94%) > upper back (2.59%) > lower back (1.65%) > lower belly (1.41%) > 
arm (1.29%) > chest (0.47%) > chin (0.35%) > upper belly (0.24%).
5. The order of the number scored 4 points from most to least: Lip (1.88%) > thigh (0.35%) = lower belly (0.35%) > lower back (0.12%) = arm (0.12%) = chest 
(0.12%1) > upper back (0%) = chin (0%) = upper belly (0%)
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In this study, we reported the degree and the distri-
bution of facial and body terminal hair in 850 Chinese 
women with PCOS, and 2,988 members of the general 
population. Table I shows the 850 PCOS patients’ FG 
scores (0–4)in nine body areas. 
According to the data above, using the Rotterdam 
criteria, from 0 to 4 points, the lip is the most common 
place (score 0–3) but the chin is not a common place that 
terminal hair grows in 850 PCOS patients. Next to the 
upper back and chest, and the number of 4 points was 
only recorded for region lip (16), thigh (3), lower belly 
(3), arm (1), chest (1), and lower back (1). None of the 
PCOS patients displayed a score of more than 4 points 
for chin, upper belly and upper back.
Table II shows the FG total score, the number as well 
as its percentiles of 850 PCOS patients, each number 
of the FG total score accounts for the total number 
Table II. The mFG score, number and percentile in nine regions 
of 850 PCOS patients
Tabela II. Wyniki w zmodyfikowanej skali Ferrimana-
Gallweya (liczba punktów i procenty) w dziewięciu okolicach 
ciała u 850 pacjentek z PCOS
FG score Number Percentile (%)
0 35 4.1
1 102 12.0
2 131 15.4
3 116 13.6
4 99 11.6
5 85 10.0
6 53 6.2
7 51 6.0
8 39 4.6
9 36 4.2
10 30 3.5
11 19 2.2
12 20 2.4
13 7 0.8
14 6 0.7
15 6 0.7
16 6 0.7
17 2 0.2
18 1 0.1
19 3 0.4
20 1 0.1
21 0 0.0
22 1 0.1
23 1 0.1
24 or above 0 0
of the percentage. Our findings showed that of the 
850 patients, 367 had a FG score equal to or greater than 
5 points [43.2% (367/850)], 282 patients had a FG score 
equal to or greater than 6 points [33.18% (282/850)], and 
21% had scores of at least 8. Nobody’s FG score was 
equal to or greater than 24 points.
Table III shows the general population: among the 
nine body areas, the most frequent areas with an mFG 
score of at least 1 were the upper lip (418 of 2988, 13.99%) 
> upper back (8.03%) > thighs (7.03%) > lower abdo-
men (6.46%); whereas for serious hair growth with an 
mFG score of at least 3, the most frequent areas were 
thighs (1.87%) > upper lip (1.07%) > forearm (0.57%) 
> lower back (0.47%). Among subjects with an mFG ≥ 5 
(n=314), the areas most often presenting with terminal 
hair growth were the upper lip (68.2%) > thighs (62.1%) 
> lower abdomen (54.5%) > upper back (52.2%). 
Figure 1 describes a scoring example of terminal hair 
growth using the mFG system in a Chinese woman with 
polycystic ovary syndrome (PCOS). We should note that 
in some women, an mFG score of 1 might be just present 
with several pieces of long, black terminal hair growing, 
such as around areola, in lower abdomen, and chin. The 
data of the control group indicated that the mFG scores 
were normally distributed in the population. Overall, an 
mFG score of at least 5 was observed in 10%, and of at 
least 2 in 25%, of all subjects. An mFG score of 5 or greater 
is out of the norm for Chinese women from the general 
unselected population. By using a score of 5 as the cutoff 
value for hirsutism [9] and according to Table II, the inci-
dence of PCOS is 43.2% in Chinese women.
Concerning the degree of hair growth among the 
nine body areas in our PCOS patients, a significant 
amount of hair was found on the lips and upper back 
in most subjects (score 1–2), but in terms of the serious 
situation (score 3–4)the lips and thighs were the most 
common places that hair grew. For the general popula-
tion, we very often gave an mFG score of 1 in the upper 
lip, and for those with excess hair growth. Compared to 
previous studies, our study represents the largest study 
of women with PCOS and the general population and 
is large enough to display the distribution of mFG score 
present in these two groups of people. 
There are a number of strengths in our present re-
port. Firstly, the study and cohort are two large groups 
of women aged 20–45; secondly, the study group con-
sisted of typical PCOS patients all diagnosed according 
to the 2003 Rotterdam criteria. The control group was 
selected by multistage systematic cluster sampling ran-
domly from the general population in different regions 
of South China. Secondly, statistically defining the 
cut-off value for hirsutism either by cluster or related 
analyses or by the relative distribution (e.g. percentile) 
was used, and the results are reasonable and credible. 
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Table III. The degree of hair growth among the nine body areas assessed by mFG score system in normal controls
Tabela III. Nasilenie wzrostu włosów w dziewięciu okolicach ciała w ocenie za pomocą zmodyfikowanej skali Ferrimana-
Gallweya u zdrowych kobiet z grupy kontrolnej
Upper lip Upper back Thighs Lower abdomenChest Upper abdomenForearm Lower back Chin
An mFG score of at least 1
N 418 240 210 193 177 152 148 142 32
% 13.99 8.03 7.03 6.46 5.92 5.09 4.95 4.75 1.07
An mFG score of at least 3
N 32 5 56 4 2 4 17 14 1
% 1.07 0.17 1.87 0.13 0.07 0.13 0.57 0.47 0.03
An mFG score of at least 1 among the subjects with mFG score ≥ 5 (n = 314) 
N 214 164 195 171 149 137 134 128 29
% 68.2 52.2 62.1 54.5 47.5 43.6 42.7 40.8 9.2 
Nine areas of mFG scoring ( total number = 2,988)
Upper lip Upper back Thighs Lower abdomen Chest Upper abdomen Forearm Lower back Chin
An mFG score of at least 1
N 418 240 210 193 177 152 148 142 32
% 13.99 8.03 7.03 6.46 5.92 5.09 4.95 4.75 1.07
An mFG score of at least 3
N 32 5 56 4 2 4 17 14 1
% 1.07 0.17 1.87 0.13 0.07 0.13 0.57 0.47 0.03
An mFG score of at least 1 among the subjects with mFG score ≥ 5 (n = 314) 
N 214 164 195 171 149 137 134 128 29
% 68.2 52.2 62.1 54.5 47.5 43.6 42.7 40.8 9.2 
Nine areas of mFG scoring ( total number = 2,988)
Figure 1. Figure describes the scoring example of terminal hair growth using the mFG system in a Chinese woman with polycystic 
ovary syndrome (PCOS). A — upper lip, score 2; B — chest, score 1; C — lower abdomen, score 1; D — upper back, score 2; E — arm, 
score 3; F — thighs, score 3
Rycina 1. Na rycinie przedstawiono przykład punktowej oceny wzrostu włosów końcowych za pomocą zmodyfikowanej skali Ferrimana-
Gallweya u Chinki z zespołem policystycznych jajników. A — górna warga, wynik 2 pkt.; B — klatka piersiowa, wynik 1 pkt.; C — 
podbrzusze, wynik 1 pkt.; D — górna część pleców, wynik 2 pkt; E — ramię, wynik 3 pkt; F — uda, wynik 3 pkt
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Conclusions
In conclusion, our data indicates that among 2,988 
women aged 20–45 randomly selected from the general 
population by multistage systematic cluster sampling, 
the normative cutoff value of mFG score for hirsutism 
is 5 in the total population. Studying PCOS patients, 
according to Tab 2, using this data we went on to define 
hirsutism by a global cutoff value for mFG of 5 or alter-
natively according to the various cutoff values. Defining 
hirsutism by a mFG score ≥ 5, 367/850 (43.3%) of subjects 
studied were diagnosable with PCOS according to the 
Rotterdam 2003 criteria [10]. For PCOS patients and 
the general population, using the Rotterdam criteria, 
hirsutism is more common in PCOS than in the gen-
eral population. From 0 to 4 points, the lip is the most 
common place, and the upper back in most subjects 
(score 1–2), but as to the serious situation (score 3–4), 
the lips and thighs are the most common places that 
hair grows. We very often gave an mFG score of 1 in 
the upper lip, and for those with excess hair growth. 
There is a good predictive value to diagnose PCOS by 
FG score for Chinese women.
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